{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:40:03Z","timestamp":1750135203122,"version":"3.41.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jcjo.2024.12.012","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T12:22:06Z","timestamp":1736770926000},"page":"e475-e476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tetracaine versus proparacaine for retinopathy of prematurity exams"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5123-5841","authenticated-orcid":false,"given":"Brandi","family":"Newby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5669-7001","authenticated-orcid":false,"given":"Maryam","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2024.12.012_bib0001","unstructured":"Jeffries AL. Retinopathy of prematurity: An update on screening and management, https:\/\/cps.ca\/en\/documents\/position\/retinopathy-of-prematurity-screening#ref20 2016 [accessed 2 Nov 2024]."},{"key":"10.1016\/j.jcjo.2024.12.012_bib0002","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/ANC.0b013e318225a332","article-title":"Physiologic effects of retinopathy of prematurity screening examinations","volume":"11","author":"Mitchell","year":"2011","journal-title":"Adv Neonatal Care"},{"key":"10.1016\/j.jcjo.2024.12.012_bib0003","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/jp.2014.154","article-title":"The neonatal pain, agitation and sedation scale and the bedside nurse's assessment of neonates","volume":"35","author":"Hillman","year":"2015","journal-title":"J Perinatol"},{"key":"10.1016\/j.jcjo.2024.12.012_bib0004","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/jop.2023.0148","article-title":"Comparison of proparacaine, tetracaine, and oxybuprocaine in corneal sensitivity measurement","volume":"40","author":"Dias","year":"2024","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jcjo.2024.12.012_bib0005","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2147\/OPTH.S66701","article-title":"Prospective, randomized, contralateral eye comparison of tetracaine and proparacaine for pain control in laser in situ keratomileusis and photorefractive keratectomy","volume":"8","author":"Moshirfar","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.12.012_bib0006","first-page":"101","article-title":"Comparison between proparacaine and tetracaine in ophthalmological topical anesthesia: a randomized, controlled and in double-blind study","volume":"54","author":"Montorio","year":"2012","journal-title":"Minerva Oftalmol"},{"key":"10.1016\/j.jcjo.2024.12.012_bib0007","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1553-2712.1994.tb02646.x","article-title":"A comparison of proparacaine and tetracaine eye anesthetics","volume":"1","author":"Bartfield","year":"1994","journal-title":"Acad Emerg Med"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224004198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224004198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T03:59:13Z","timestamp":1750132753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418224004198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0008418224004198"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.12.012","relation":{},"ISSN":["0008-4182"],"issn-type":[{"type":"print","value":"0008-4182"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetracaine versus proparacaine for retinopathy of prematurity exams","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}